• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SWI/SNF 核小体重塑因子与癌症。

SWI/SNF nucleosome remodellers and cancer.

机构信息

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Children's Hospital Boston, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Nat Rev Cancer. 2011 Jun 9;11(7):481-92. doi: 10.1038/nrc3068.

DOI:10.1038/nrc3068
PMID:21654818
Abstract

SWI/SNF chromatin remodelling complexes use the energy of ATP hydrolysis to remodel nucleosomes and to modulate transcription. Growing evidence indicates that these complexes have a widespread role in tumour suppression, as inactivating mutations in several SWI/SNF subunits have recently been identified at a high frequency in a variety of cancers. However, the mechanisms by which mutations in these complexes drive tumorigenesis are unclear. In this Review we discuss the contributions of SWI/SNF mutations to cancer formation, examine their normal functions and discuss opportunities for novel therapeutic interventions for SWI/SNF-mutant cancers.

摘要

SWI/SNF 染色质重塑复合物利用 ATP 水解的能量重塑核小体并调节转录。越来越多的证据表明,这些复合物在肿瘤抑制中具有广泛的作用,因为最近在各种癌症中高频发现了几种 SWI/SNF 亚基的失活突变。然而,这些复合物中的突变驱动肿瘤发生的机制尚不清楚。在这篇综述中,我们讨论了 SWI/SNF 突变对癌症形成的贡献,研究了它们的正常功能,并讨论了针对 SWI/SNF 突变型癌症的新型治疗干预的机会。

相似文献

1
SWI/SNF nucleosome remodellers and cancer.SWI/SNF 核小体重塑因子与癌症。
Nat Rev Cancer. 2011 Jun 9;11(7):481-92. doi: 10.1038/nrc3068.
2
The SWI/SNF complex and cancer.SWI/SNF复合物与癌症。
Oncogene. 2009 Apr 9;28(14):1653-68. doi: 10.1038/onc.2009.4. Epub 2009 Feb 23.
3
BAFfling pathologies: Alterations of BAF complexes in cancer.BAF 相关病变:癌症中 BAF 复合物的改变。
Cancer Lett. 2018 Apr 10;419:266-279. doi: 10.1016/j.canlet.2018.01.046. Epub 2018 Jan 31.
4
Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.人类癌症中 SWI/SNF 染色质重塑基因的失活突变。
Jpn J Clin Oncol. 2013 Sep;43(9):849-55. doi: 10.1093/jjco/hyt101. Epub 2013 Jul 30.
5
SWI/SNF chromatin remodeling and human malignancies.SWI/SNF 染色质重塑与人类恶性肿瘤。
Annu Rev Pathol. 2015;10:145-71. doi: 10.1146/annurev-pathol-012414-040445. Epub 2014 Oct 27.
6
SWI/SNF chromatin remodeling complexes and cancer.SWI/SNF染色质重塑复合物与癌症
Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):350-66. doi: 10.1002/ajmg.c.31410. Epub 2014 Aug 28.
7
[Chromatin remodeling defects and cancer: the SWI/SNF example].[染色质重塑缺陷与癌症:SWI/SNF 实例]
Bull Cancer. 2012 Dec;99(12):1133-40. doi: 10.1684/bdc.2012.1664.
8
The SWI/SNF complex--chromatin and cancer.SWI/SNF复合物——染色质与癌症
Nat Rev Cancer. 2004 Feb;4(2):133-42. doi: 10.1038/nrc1273.
9
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.SMARCB1缺失驱动横纹肌肉瘤生长的机制。
Cancer Genet. 2014 Sep;207(9):365-72. doi: 10.1016/j.cancergen.2014.04.004. Epub 2014 Apr 13.
10
Genetic variant in SWI/SNF complexes influences hepatocellular carcinoma risk: a new clue for the contribution of chromatin remodeling in carcinogenesis.SWI/SNF复合物中的基因变异影响肝细胞癌风险:染色质重塑在致癌过程中作用的新线索
Sci Rep. 2014 Feb 21;4:4147. doi: 10.1038/srep04147.

引用本文的文献

1
ACTL6A depletion induces KLF4-mediated anti-tumorigenic effects in colorectal cancer.ACTL6A缺失在结直肠癌中诱导KLF4介导的抗肿瘤作用。
Cell Death Dis. 2025 Aug 28;16(1):653. doi: 10.1038/s41419-025-07946-w.
2
Updates on Pulmonary Neuroendocrine Carcinoids: Progress and Perspectives.肺神经内分泌类癌的最新进展:进展与展望
J Clin Med. 2025 Aug 13;14(16):5733. doi: 10.3390/jcm14165733.
3
A case report of SMARCA2-deficient and SMARCA4-preserved lung adenocarcinoma diagnosed by pleural effusion cytology.一例经胸腔积液细胞学诊断的SMARCA2缺陷型和SMARCA4保留型肺腺癌病例报告。

本文引用的文献

1
Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors.大规模平行 DNA 焦磷酸测序分析肺原发病灶中的肿瘤抑制因子 BRG1/SMARCA4。
Hum Mutat. 2011 Feb;32(2):E1999-2017. doi: 10.1002/humu.21415. Epub 2010 Dec 7.
2
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.外显子组测序鉴定出肾癌中 SWI/SNF 复合物基因 PBRM1 的高频突变。
Nature. 2011 Jan 27;469(7331):539-42. doi: 10.1038/nature09639. Epub 2011 Jan 19.
3
Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1.
BMC Pulm Med. 2025 Aug 26;25(1):406. doi: 10.1186/s12890-025-03891-8.
4
BRG1 inhibits glycolysis by promoting SHP1-mediated dephosphorylation of PKM2 in non-small cell lung cancer.在非小细胞肺癌中,BRG1通过促进SHP1介导的PKM2去磷酸化来抑制糖酵解。
Oncogenesis. 2025 Aug 24;14(1):32. doi: 10.1038/s41389-025-00577-y.
5
Small bowel metastatic SWI/SNF-deficient undifferentiated carcinoma may be predictive of lung primary-a rare presentation with novel SMARCA2 mutation findings in a study of three cases.小肠转移性SWI/SNF缺陷未分化癌可能提示原发性肺癌——在一项三例病例研究中的罕见表现及新型SMARCA2突变发现
Virchows Arch. 2025 Aug 7. doi: 10.1007/s00428-025-04208-0.
6
Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy Strategy.Ph样B淋巴细胞白血病对BRG1抑制的选择性敏感性揭示了一种新型靶向治疗策略。
bioRxiv. 2025 Jul 11:2025.07.08.661805. doi: 10.1101/2025.07.08.661805.
7
The Mgv1-Rlm1 axis orchestrates SAGA and SWI/SNF complexes at target promoters.Mgv1-Rlm1轴在靶基因启动子处协调SAGA和SWI/SNF复合物。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf653.
8
Epigenetic modifications and their roles in pediatric brain tumor formation: emerging insights from chromatin dysregulation.表观遗传修饰及其在儿童脑肿瘤形成中的作用:染色质失调的新见解
Front Oncol. 2025 Jun 17;15:1569548. doi: 10.3389/fonc.2025.1569548. eCollection 2025.
9
Epigenetic regulators in cancer therapy and progression.癌症治疗与进展中的表观遗传调控因子
NPJ Precis Oncol. 2025 Jun 28;9(1):206. doi: 10.1038/s41698-025-01003-7.
10
The Dynamic Interactions of m6A Modification and R-Loops: Implications for Genome Stability.m6A修饰与R环的动态相互作用:对基因组稳定性的影响
Epigenomes. 2025 Jun 11;9(2):21. doi: 10.3390/epigenomes9020021.
针对因 Ini1 缺失而引发的原发性肿瘤中细胞周期蛋白 D1 的治疗靶向。
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):319-24. doi: 10.1073/pnas.0913297108. Epub 2010 Dec 20.
4
The genetic landscape of the childhood cancer medulloblastoma.儿童癌症髓母细胞瘤的遗传特征。
Science. 2011 Jan 28;331(6016):435-9. doi: 10.1126/science.1198056. Epub 2010 Dec 16.
5
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.肿瘤抑制因子 Snf5 的缺失会导致 Hedgehog-Gli 信号通路的异常激活。
Nat Med. 2010 Dec;16(12):1429-33. doi: 10.1038/nm.2251. Epub 2010 Nov 14.
6
Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.SMARCB1/INI1 表达缺失见于低分化 chordoma 肿瘤。
Acta Neuropathol. 2010 Dec;120(6):745-53. doi: 10.1007/s00401-010-0767-x. Epub 2010 Oct 30.
7
Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.抑癌基因与癌基因的表达调控
Cancer Cell. 2010 Oct 19;18(4):316-28. doi: 10.1016/j.ccr.2010.09.006.
8
ARID1A mutations in endometriosis-associated ovarian carcinomas.ARID1A 突变与子宫内膜异位症相关的卵巢癌。
N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8.
9
Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.家族性多发性脑膜瘤中的胚系 SMARCB1 突变和体细胞 NF2 突变。
J Med Genet. 2011 Feb;48(2):93-7. doi: 10.1136/jmg.2010.082420. Epub 2010 Oct 7.
10
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.卵巢透明细胞癌中染色质重塑基因 ARID1A 的频繁突变。
Science. 2010 Oct 8;330(6001):228-31. doi: 10.1126/science.1196333. Epub 2010 Sep 8.